[1] |
Davatzikos C, Resnick SM, Wu X, et al.
Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI[J]. NeuroimageNeuroimage, 2008, 41(4): 1220-1227.
doi: 10.1016/j.neuroimage.2008.03.050
|
[2] |
Jack CR Jr, Knopman DS, Jagust WJ, et al.
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade[J]. Lancet NeurolLancet Neurol, 2010, 9(1): 119-128.
|
[3] |
Dubois B, Feldman HH, Jacova C, et al.
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria[J]. Lancet NeurolLancet Neurol, 2007, 6(8): 734-746.
|
[4] |
Krishnan S, Talley BD, Slavin MJ, et al.
Current status of functional MR imaging, perfusion-weighted imaging, and diffusion-tensor imaging in Alzheimer's disease diagnosis and research[J]. Neuro-imaging Clin N AmNeuro-imaging Clin N Am, 2005, 15(4): 853-868, xi.
|
[5] |
Jack CR Jr, Petersen RC, Xu Y, et al.
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD[J]. NeurologyNeurology, 2000, 55(4): 484-489.
doi: 10.1212/WNL.55.4.484
|
[6] |
Goldszal AF, Davatzikos C, Pham DL, et al.
An image-processing system for qualitative and quantitative volumetric analysis of brain images[J]. J Comput Assist TomogrJ Comput Assist Tomogr, 1998, 22(5): 827-837.
|
[7] |
Fein G, Landman B, Tran H, et al.
Statistical parametric mapping of brain morphology: sensitivity is dramatically increased by using brain-extracted images as inputs[J]. Neuro-imageNeuro-image, 2006, 30(4): 1187-1195.
|
[8] |
Whitwell JL, Jack CR Jr.
Neuroimaging in dementia[J]. Neurol ClinNeurol Clin, 2007, 25(3): 843-857.
doi: 10.1016/j.ncl.2007.03.003
|
[9] |
Kantarci K, Petersen RC, Przybelski SA, et al.
Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cere brovascular disease in mild cognitive impairment subtypes[J]. Arch NeurolArch Neurol, 2008, 65(12): 1621-1628.
|
[10] |
Whitwell JL, Przybelski SA, Weigand SD, et al.
3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease[J]. BrainBrain, 2007, 130(Pt7): 1777-1786.
|
[11] |
Broe M, Hodges JR, Schofield E, et al.
Staging disease severity in pathologically confirmed cases of frontotemporal dementia[J]. NeurologyNeurology, 2003, 60(6): 1005-1011.
doi: 10.1212/01.WNL.0000052685.09194.39
|
[12] |
Kitagaki H, Mori E, Yamaji S, et al.
Frontotemporal dementia and Alzheimer disease: evaluation of cortical atrophy with automated hemispheric surface display generated with MR images[J]. RadiologyRadiology, 1998, 208(2): 431-439.
doi: 10.1148/radiology.208.2.9680572
|
[13] |
Laakso MP, Frisoni GB, Könönen M, et al.
Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: a morphometric MRI study[J]. Biol PsychiatryBiol Psychiatry, 2000, 47(12): 1056-1063.
doi: 10.1016/S0006-3223(99)00306-6
|
[14] |
No authors listed.
Clinical and neuropathological criteria for frontotemporal dementia.The Lund and Manchester Groups[J]. J Neurol Neurosurg PsychiatryJ Neurol Neurosurg Psychiatry, 1994, 57(4): 416-418.
doi: 10.1136/jnnp.57.4.416
|
[15] |
Kenny ER, Burton EJ, O'Brien JT.
A volumetric magnetic resonance imaging study of entorhinal cortex volume in dementia with Lewy bodies.A comparison with Alzheimer's disease and Parkinson's disease with and without dementia[J]. Dement Geriatr Cogn DisordDement Geriatr Cogn Disord, 2008, 26(3): 218-225.
|
[16] |
Kantarci K, Avula R, Senjem ML, et al.
Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI[J]. NeurologyNeurology, 2010, 74(22): 1814-1821.
doi: 10.1212/WNL.0b013e3181e0f7cf
|
[17] |
Klucken J, McLean PJ, Gomez-Tortosa E, et al.
Neuritic alterations and neural system dysfunction in Alzheimer's disease and dementiawith Lewy bodies[J]. Neurochem ResNeurochem Res, 2003, 28(11): 1683-1691.
doi: 10.1023/A:1026061021946
|
[18] |
Whitwell JL, Weigand SD, Shiung MM, et al.
Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease[J]. BrainBrain, 2007, 130(Pt3): 708-719.
|
[19] |
Sanak D, Nosál'V, Horák D, et al.
Impact of diffusion-weighted MRI-measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis[J]. NeuroradiologyNeuroradiology, 2006, 48(9): 632-639.
doi: 10.1007/s00234-006-0105-0
|
[20] |
Kantarci K, Petersen RC, Boeve BF, et al.
DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment[J]. NeurologyNeurology, 2005, 64(5): 902-904.
doi: 10.1212/01.WNL.0000153076.46126.E9
|
[21] |
Fellgiebel A, Müller MJ, Wille P, et al.
Color-coded diffusiontensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment[J]. Neurobiol AgingNeurobiol Aging, 2005, 26(8): 1193-1198.
doi: 10.1016/j.neurobiolaging.2004.11.006
|
[22] |
Zhang B, Li M, Sun ZZ, et al.
Evaluation of functional MRI markers in mild cognitive impairment[J]. J Clin NeurosciJ Clin Neurosci, 2009, 16(5): 635-641.
doi: 10.1016/j.jocn.2008.07.080
|
[23] |
Mayzel-Oreg O, Assaf Y, Gigi A, et al.
High b-value diffusion imaging of dementia: application to vascular dementia and alzheimer disease[J]. JNeurolSciJNeurolSci, 2007, 257(1-2): 105-113.
|
[24] |
Zhang Y, Schuff N, Du AT, et al.
White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI[J]. BrainBrain, 2009, 132(Pt9): 2579-2592.
|
[25] |
Matsuo K, Mizuno T, Yamada K, et al.
Cerebral white matter damage in frontotemporal dementia assessed by diffusion tensor tractography[J]. NeuroradiologyNeuroradiology, 2008, 50(7): 605-611.
doi: 10.1007/s00234-008-0379-5
|
[26] |
Kantarci K, Reynolds G, Petersen RC, et al.
Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T[J]. AJNR Am J NeuroradiolAJNR Am J Neuroradiol, 2003, 24(5): 843-849.
|
[27] |
Norfray JF, Provenzale JM.
Alzheimer's disease: neuropathologic findings and recent advances in imaging[J]. AJR Am J RoentgenolAJR Am J Roentgenol, 2004, 182(1): 3-13.
doi: 10.2214/ajr.182.1.1820003
|
[28] |
Kantarci K, Smith GE, Ivnik RJ, et al.
1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease[J]. J Int Neuropsychol SocJ Int Neuropsychol Soc, 2002, 8(7): 934-942.
|
[29] |
Coulthard E, Firbank M, English P, et al.
Proton magnetic resonance spectroscopy in frontotemporal dementia[J]. J NeurolJ Neurol, 2006, 253(7): 861-868.
doi: 10.1007/s00415-006-0045-y
|
[30] |
Ernst T, Chang L, Melchor R, et al.
Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy[J]. RadiologyRadiology, 1997, 203(3): 829-836.
doi: 10.1148/radiology.203.3.9169712
|
[31] |
Kantarci K, Petersen RC, Boeve BF, et al.
1H MR spectroscopy in common dementias[J]. NeurologyNeurology, 2004, 63(8): 1393-1398.
doi: 10.1212/01.WNL.0000141849.21256.AC
|
[32] |
Liu GR, Gao PY, Lin Y, et al.
Brain magnetic resonance elastography on healthy volunteers: a safety study[J]. Acta RadiolActa Radiol, 2009, 50(4): 423-429.
doi: 10.1080/02841850902751681
|